Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7,587 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development of an inactivated vaccine candidate for SARS-CoV-2.
Gao Q, Bao L, Mao H, Wang L, Xu K, Yang M, Li Y, Zhu L, Wang N, Lv Z, Gao H, Ge X, Kan B, Hu Y, Liu J, Cai F, Jiang D, Yin Y, Qin C, Li J, Gong X, Lou X, Shi W, Wu D, Zhang H, Zhu L, Deng W, Li Y, Lu J, Li C, Wang X, Yin W, Zhang Y, Qin C. Gao Q, et al. Among authors: jiang d. Science. 2020 Jul 3;369(6499):77-81. doi: 10.1126/science.abc1932. Epub 2020 May 6. Science. 2020. PMID: 32376603 Free PMC article.
Safety and Immunogenicity of Sabin Strain Inactivated Poliovirus Vaccine Compared With Salk Strain Inactivated Poliovirus Vaccine, in Different Sequential Schedules With Bivalent Oral Poliovirus Vaccine: Randomized Controlled Noninferiority Clinical Trials in China.
Hu Y, Xu K, Han W, Chu K, Jiang D, Wang J, Tian X, Ying Z, Zhang Y, Li C, Zhu F. Hu Y, et al. Among authors: jiang d. Open Forum Infect Dis. 2019 Aug 26;6(10):ofz380. doi: 10.1093/ofid/ofz380. eCollection 2019 Oct. Open Forum Infect Dis. 2019. PMID: 31660344 Free PMC article.
Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials.
Zeng G, Wu Q, Pan H, Li M, Yang J, Wang L, Wu Z, Jiang D, Deng X, Chu K, Zheng W, Wang L, Lu W, Han B, Zhao Y, Zhu F, Yu H, Yin W. Zeng G, et al. Among authors: jiang d. Lancet Infect Dis. 2022 Apr;22(4):483-495. doi: 10.1016/S1473-3099(21)00681-2. Epub 2021 Dec 8. Lancet Infect Dis. 2022. PMID: 34890537 Free PMC article. Clinical Trial.
Safety, immunogenicity, and lot-to-lot consistency of a multidose Sabin strain-based inactivated polio vaccine: a phase III, randomized, blinded, positive-control clinical trial in infants aged 2 months.
Feng G, Jiang D, Han W, Xie Z, Jiang Z, Huang L, Wang J, Zhang W, Xu L, Tan J, You W, Cui G, Li C, Wang Y. Feng G, et al. Among authors: jiang d, jiang z. Int J Infect Dis. 2023 May;130:20-27. doi: 10.1016/j.ijid.2023.01.020. Epub 2023 Jan 20. Int J Infect Dis. 2023. PMID: 36682682 Free article. Clinical Trial.
Safety, Immunogenicity and Lot-to-Lot Consistency of Sabin-Strain Inactivated Poliovirus Vaccine in 2-Month-Old Infants: A Double-Blind, Randomized Phase III Trial.
Zheng Y, Ying Z, Zou Y, Zhu T, Qian D, Han W, Jiang Y, Jiang Z, Li X, Wang J, Lei J, Xu L, Jiang D, Li C, Liu X. Zheng Y, et al. Among authors: jiang d, jiang z, jiang y. Vaccines (Basel). 2022 Feb 8;10(2):254. doi: 10.3390/vaccines10020254. Vaccines (Basel). 2022. PMID: 35214712 Free PMC article.
7,587 results